Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

BioDelivery
FDA Approves BELBUCA — BioDelivery Sciences International Inc

BioDelivery Sciences International Inc. announced the FDA approval of BELBUCA, a buccal film intended for the management of moderate to severe chronic...

WG
FDA Approves DEXMEDETOMIDINE — WG Critical Care, LLC

# FDA Approves WG Critical Care's Dexmedetomidine Injection for Intravenous Use WG Critical Care, LLC has received FDA approval for its intravenous d...

Apotex
FDA Approves IBANDRONATE SODIUM — Apotex Corp.

# FDA Approves Apotex's Generic Ibandronate Sodium Injection Apotex Corp. received FDA approval for its generic ibandronate sodium intravenous formul...

PAI
FDA Approves BUPRENORPHINE AND NALOXONE — PAI Holdings, LLC dba PAI Pharma

PAI Holdings, LLC dba PAI Pharma has received FDA approval for its Abbreviated New Drug Application (ANDA 204431) for Buprenorphine Hydrochloride and ...

Epic
FDA Approves OXYCODONE HYDROCHLORIDE — Epic Pharma, LLC

Epic Pharma, LLC received final FDA approval on September 22, 2015, for its ANDA for oxycodone hydrochloride oral solution, adding a critical generic ...

Aurolife
FDA Approves METHADONE HYDROCHLORIDE — Aurolife Pharma, LLC

# FDA Approves Aurolife Pharma's Generic Methadone Hydrochloride Aurolife Pharma, LLC has received FDA approval for its generic methadone hydrochlori...

Boehringer
FDA Approves SYNJARDY — Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc. announced the FDA approval of SYNJARDY (empagliflozin and metformin hydrochloride tablets), combining two w...

Novel
FDA Approves OXYCODONE HYDROCHLORIDE — Novel Laboratories, Inc.

The FDA has granted final approval to Novel Laboratories, Inc. for its Abbreviated New Drug Application (ANDA) involving oxycodone hydrochloride, posi...

Alembic
FDA Approves CELECOXIB — Alembic Pharmaceuticals Inc.

Alembic Pharmaceuticals Inc. has received U.S. FDA approval for the generic version of the prescription osteoarthritis medication Celecoxib (API Name)...

Epic
FDA Approves METHADONE HYDROCHLORIDE — Epic Pharma, LLC

On August 18, 2015, Epic Pharma, LLC received approval for ANDA090065 to manufacture generic methadone hydrochloride tablets, a move expected to inten...

BAXTER
FDA Approves Unknown Drug — BAXTER HLTHCARE CORP

BAXTER HLTHCARE CORP received FDA approval on August 7, 2015, signaling a regulatory milestone that is poised to bolster the company's market position...

Amneal
FDA Approves DEXMETHYLPHENIDATE HYDROCHLORIDE — Amneal Pharmaceuticals of New York LLC

Amneal Pharmaceuticals of New York LLC announced late Friday that the FDA has granted tentative approval for its generic version of the ADHD medicatio...

PERRIGO
FDA Approves Unknown Drug — PERRIGO R AND D

FDA has accepted PERRIGO R AND D’s ANDA #204152, signaling the initiation of a pathway for a critical dosage form and highlighting the company's strat...

Vertex
FDA Approves ORKAMBI — Vertex Pharmaceuticals Incorporated

# FDA Approves Vertex Pharmaceuticals' ORKAMBI for Cystic Fibrosis Vertex Pharmaceuticals Incorporated received FDA approval for ORKAMBI (lumacaftor ...

Mainpointe
FDA Approves TUXARIN — Mainpointe Pharmaceuticals

Mainpointe Pharmaceuticals announced Tuesday that the FDA has approved TUXARIN (codeine phosphate and chlorpheniramine maleate), introducing a new bra...

Eugia
FDA Approves AZITHROMYCIN — Eugia US LLC

Eugia US LLC received FDA approval for the intravenous generic version of azithromycin (ANDA 203294). This addition is expected to enhance generic mar...

Hospira,
FDA Approves LINEZOLID — Hospira, Inc.

Hospira, Inc. announced the FDA approval of its Linezolid Intravenous formulation, expanding the company's critically important portfolio of antibioti...

PHARMOBEDIENT
FDA Approves Unknown Drug — PHARMOBEDIENT

Pfizer Inc. has received approval for key filings related to its ANDA206456, filling a pivotal gap in the U.S. generic market for EchoPharm's branded ...

Saptalis
FDA Approves DESOXIMETASONE — Saptalis Pharmaceuticals, LLC.

# FDA Approves Saptalis Pharmaceuticals' Generic Desoximetasone Topical Treatment Saptalis Pharmaceuticals, LLC has received FDA approval for its gen...

Advagen
FDA Approves BUPRENORPHINE HYDROCHLORIDE — Advagen Pharma Ltd

Advagen Pharma Ltd has received FDA approval for its Abbreviated New Drug Application (ANDA090279) to market buprenorphine hydrochloride tablets for s...